IDiyas

For the Inventor, By the Inventor

Silver Spring, MD, United States of America

United Therapeutics Corporation


USPTO Granted Patents = 125



Trademarks = 28

Forward Citations = 2,527


where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents


165 inventors (with patents filed for the assignee):

goldMedal Hitesh Batra (32 out of 44 patents)

silverMedal Roger Jeffs (22 out of 22 patents)

bronzeMedal Michael Wade (20 out of 21 patents)

4.  Ken Phares (17 out of 17 patents)

5.  David A Walsh (17 out of 20 patents)

6.  Sudersan M Tuladhar (16 out of 26 patents)

7.  Raju A Penmasta (15 out of 27 patents)

8.  Liang Guo (14 out of 23 patents)

9.  David Mottola (13 out of 13 patents)

10.  Thomas Petersen (12 out of 14 patents)

11.  Roger M Ilagan (12 out of 20 patents)

12.  Vijay Sharma (8 out of 15 patents)

13.  Raymond A Dwek (7 out of 62 patents)

14.  Lewis J Rubin (7 out of 9 patents)

15.  Kenneth R Phares (7 out of 13 patents)


125 patents:

1. 12458015 - Automated bioreactor system, system for automatically implementing protocol for decellularizing organ, and waste decontamination system (2025-11-04),
2. 12397895 - Structural features of a vehicle having utility to transport high value things (2025-08-26),
3. 12358946 - Method for purifying antibodies (2025-07-15),
4. 12357599 - Prodrugs of treprostinil (2025-07-15),
5. 12310992 - Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells (2025-05-27),
6. 12274684 - Treatment of vasculopathy with prostacyclin and mesenchymal stem cells (2025-04-14),
7. 12173021 - Treprostinil prodrugs (2024-12-24),
8. 12168071 - Treprostinil derivatives and their use in pharmaceutical compositions (2024-12-17),
9. 12162853 - Synthesis of esuberaprost prodrugs (2024-12-10),
10. 12098116 - Crystalline prostacyclin (IP) receptor agonist and uses thereof (2024-09-24),
11. 12097028 - Drug delivery device with electrically controlled volume changing means (2024-09-24),
12. 12022823 - Automated bioreactor system, system for automatically implementing protocol for decellularizing organ, and waste decontamination system (2024-07-02),
13. 12017989 - Controlled release pharmaceutical formulations (2024-06-25),
14. 11839631 - Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells (2023-12-12),
15. 11839596 - Treatment of vasculopathy with prostacyclin and mesenchymal stem cells (2023-12-12),
United Therapeutics Corporation is a biotechnology company specializing in the development and commercialization of innovative therapies for patients with rare and chronic diseases. The company focuses on diseases such as pulmonary arterial hypertension, neuroblastoma, and cancer. Through its research and development efforts, United Therapeutics aims to improve the lives of patients around the world. For more information, please visit their official website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

...
125 Patents

#1 in Silver Spring, MD

#21 in Maryland

#2,979 in US

#6,210 in the World

...
Silver Spring, MD, United States of America

United Therapeutics Corporation

Forward Citations = 2,527

165 inventors:

goldMedal Hitesh Batra (32 out of 44 patents)

silverMedal Roger Jeffs (22 out of 22 patents)

bronzeMedal Michael Wade (20 out of 21 patents)

4.  Ken Phares (17 out of 17 patents)

5.  David A Walsh (17 out of 20 patents)

Please report any incorrect information to support@idiyas.com
Loading…